-
Je něco špatně v tomto záznamu ?
Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine
J. Hammerová, S. Uldrijan, E. Táborská, AH. Vaculová, I. Slaninová,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10236
MZ0
CEP - Centrální evidence projektů
PubMed
22944669
DOI
10.1515/hsz-2011-0279
Knihovny.cz E-zdroje
- MeSH
- adenin analogy a deriváty farmakologie MeSH
- autofagie účinky léků MeSH
- benzofenantridiny antagonisté a inhibitory farmakologie MeSH
- imidazoly farmakologie MeSH
- indoly farmakologie MeSH
- kaspasy metabolismus MeSH
- lidé MeSH
- melanom patologie MeSH
- nádorové buněčné linie MeSH
- nekróza chemicky indukované MeSH
- proteiny asociované s mikrotubuly metabolismus MeSH
- protinádorové látky antagonisté a inhibitory farmakologie MeSH
- protoonkogenní proteiny c-bcl-2 metabolismus MeSH
- regulace genové exprese u nádorů účinky léků MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
We show that the plant quaternary benzo[c]phenanthridine alkaloid sanguilutine (SL) is a strong inducer of caspase-independent non-apoptotic death in human melanoma cells. Necrostatin-1, a specific inhibitor of necroptosis, completely reversed the cytotoxic effect of SL, suggesting that necroptosis was a predominant type of cell death induced by SL in these cells. In addition, we showed that SL can trigger an autophagic response, as confirmed by GFP-LC3 puncta formation and LC3-II accumulation. Interestingly, we observed a significant decrease in the viability of melanoma cells treated with combination of autophagy inhibitors (3-methyladenine, bafilomycin-A1 and LY294002) and SL. Our results further indicated that autophagy may serve as a pro-survival mechanism, delaying the induction of necroptosis in melanoma cells. The ability of SL to induce caspase-independent non-apoptotic cell death (necroptosis) suggests its possible therapeutic potential in the treatment of apoptosis-resistant melanoma tumours. Furthermore, SL might serve as a useful tool for studying the mechanisms of necroptosis and autophagy induction and the interplay between these two processes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012487
- 003
- CZ-PrNML
- 005
- 20141111103856.0
- 007
- ta
- 008
- 130404s2012 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/hsz-2011-0279 $2 doi
- 035 __
- $a (PubMed)22944669
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Hammerová, Jindřiška $u Department of Biology, Masaryk University, Kamenice Brno, Czech Republic.
- 245 10
- $a Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine / $c J. Hammerová, S. Uldrijan, E. Táborská, AH. Vaculová, I. Slaninová,
- 520 9_
- $a We show that the plant quaternary benzo[c]phenanthridine alkaloid sanguilutine (SL) is a strong inducer of caspase-independent non-apoptotic death in human melanoma cells. Necrostatin-1, a specific inhibitor of necroptosis, completely reversed the cytotoxic effect of SL, suggesting that necroptosis was a predominant type of cell death induced by SL in these cells. In addition, we showed that SL can trigger an autophagic response, as confirmed by GFP-LC3 puncta formation and LC3-II accumulation. Interestingly, we observed a significant decrease in the viability of melanoma cells treated with combination of autophagy inhibitors (3-methyladenine, bafilomycin-A1 and LY294002) and SL. Our results further indicated that autophagy may serve as a pro-survival mechanism, delaying the induction of necroptosis in melanoma cells. The ability of SL to induce caspase-independent non-apoptotic cell death (necroptosis) suggests its possible therapeutic potential in the treatment of apoptosis-resistant melanoma tumours. Furthermore, SL might serve as a useful tool for studying the mechanisms of necroptosis and autophagy induction and the interplay between these two processes.
- 650 _2
- $a adenin $x analogy a deriváty $x farmakologie $7 D000225
- 650 _2
- $a protinádorové látky $x antagonisté a inhibitory $x farmakologie $7 D000970
- 650 _2
- $a autofagie $x účinky léků $7 D001343
- 650 _2
- $a benzofenantridiny $x antagonisté a inhibitory $x farmakologie $7 D053119
- 650 _2
- $a kaspasy $x metabolismus $7 D020169
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imidazoly $x farmakologie $7 D007093
- 650 _2
- $a indoly $x farmakologie $7 D007211
- 650 _2
- $a melanom $x patologie $7 D008545
- 650 _2
- $a proteiny asociované s mikrotubuly $x metabolismus $7 D008869
- 650 _2
- $a nekróza $x chemicky indukované $7 D009336
- 650 _2
- $a protoonkogenní proteiny c-bcl-2 $x metabolismus $7 D019253
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Uldrijan, Stjepan $u -
- 700 1_
- $a Táborská, Eva $u -
- 700 1_
- $a Vaculová, Alena Hyršlová $u -
- 700 1_
- $a Slaninová, Iva $u -
- 773 0_
- $w MED00005521 $t Biological chemistry $x 1437-4315 $g Roč. 393, č. 7 (2012), s. 647-58
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22944669 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20141111103909 $b ABA008
- 999 __
- $a ok $b bmc $g 975685 $s 810768
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 393 $c 7 $d 647-58 $i 1437-4315 $m Biological chemistry $n Biol Chem $x MED00005521
- GRA __
- $a NS10236 $p MZ0
- LZP __
- $a Pubmed-20130404